Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
出版年份 2014 全文链接
标题
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis
作者
关键词
Peritoneal carcinomatosis, HIPEC, Irinotecan, Oxaliplatin, Morbidity, Survival
出版物
BMC CANCER
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2014-11-04
DOI
10.1186/1471-2407-14-807
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from digestive tract cancer—New management with oxaliplatin plus irinotecan: A feasibility study in 37 patients
- (2017) F. Quenet et al. JOURNAL OF CLINICAL ONCOLOGY
- Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
- (2014) Quentin Chalret du Rieu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial
- (2013) Gabriel Glockzin et al. BMC CANCER
- The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study
- (2013) D. Hompes et al. JOURNAL OF SURGICAL ONCOLOGY
- S3-Leitlinie Kolorektales Karzinom Version 1.0 - Juni 2013 AWMF-Registernummer: 021/007OL
- (2013) C. Pox et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
- (2012) Daphne Hompes et al. ANNALS OF SURGICAL ONCOLOGY
- Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy
- (2012) Sabino Zani et al. JOURNAL OF SURGICAL ONCOLOGY
- Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: A matched-pair analysis
- (2012) Gabriel Glockzin et al. JOURNAL OF SURGICAL ONCOLOGY
- A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis
- (2012) Dong Hyun Lee et al. Cancer Research and Treatment
- Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis
- (2011) François Quenet et al. ANNALS OF SURGERY
- Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study
- (2011) Eddy Cotte et al. ANNALS OF SURGICAL ONCOLOGY
- Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841
- (2011) Jan Franko et al. JOURNAL OF CLINICAL ONCOLOGY
- A Comparative Study of Complete Cytoreductive Surgery Plus Intraperitoneal Chemotherapy to Treat Peritoneal Dissemination From Colon, Rectum, Small Bowel, and Nonpseudomyxoma Appendix
- (2010) Dominique Elias et al. ANNALS OF SURGERY
- Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy
- (2010) Olivier Glehen et al. CANCER
- Hyperthermic intraperitoneal chemotherapy: Rationale and technique
- (2010) Santiago González-Moreno World Journal of Gastrointestinal Oncology
- Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?
- (2009) Terence C. Chua et al. ANNALS OF SURGERY
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
- (2009) Dominique Elias et al. JOURNAL OF CLINICAL ONCOLOGY
- Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
- (2009) Gabriel Glockzin et al. World Journal of Surgical Oncology
- Multivisceral Resection Does Not Affect Morbidity and Survival After Cytoreductive Surgery and Chemoperfusion for Carcinomatosis from Colorectal Cancer
- (2008) Jan Franko et al. ANNALS OF SURGICAL ONCOLOGY
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
- (2008) Vic J. Verwaal et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion
- (2008) H. Mahteme et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
- (2008) Dominique Elias et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now